The management of cerebral palsy: subjectivity and a conundrum.
Bodensteiner
J B
JB
D001418:Baclofen / Q000627:therapeutic use*; D001905:Botulinum Toxins / Q000627:therapeutic use*; D002547:Cerebral Palsy / Q000150:complications*; D003620:Dantrolene / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009125:Muscle Relaxants, Central / Q000009:adverse effects / Q000627:therapeutic use*; D009128:Muscle Spasticity / Q000188:drug therapy* / Q000209:etiology*
D009125:Muscle Relaxants, Central; D001905:Botulinum Toxins; D003620:Dantrolene; D001418:Baclofen